Prevention Clinical Trials in Montreal, Quebec
2 recruitingMontreal, Quebec, Canada
Showing 1–2 of 2 trials
Recruiting
Phase 3
Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients
PreventionNausea and Vomiting, Postoperative
Centre hospitalier de l'Université de Montréal (CHUM)260 enrolled1 locationNCT07248280
Recruiting
Phase 1Phase 2
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Prevention of Rejection in Kidney Transplant
Eledon Pharmaceuticals48 enrolled9 locationsNCT05027906